Giglio N - Search Results

1

The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses.

Fisman D, Giglio N, Levin MJ, Nguyen VH, Pelton SI, Postma M, Ruiz-Aragón J, Urueña A, Mould-Quevedo JF. Fisman D, et al. Among authors: giglio n. Hum Vaccin Immunother. 2024 Dec 31;20(1):2351675. doi: 10.1080/21645515.2024.2351675. Epub 2024 Jun 4. Hum Vaccin Immunother. 2024. PMID: 38835218 Free PMC article. Review.

2

Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina.

Giglio ND, Cane AD, Micone P, Gentile A. Giglio ND, et al. Vaccine. 2010 Mar 8;28(11):2302-10. doi: 10.1016/j.vaccine.2009.12.070. Epub 2010 Jan 9. Vaccine. 2010. PMID: 20064478

3

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Giglio N, Gentile A, Jimenez SG, Jáuregui B, Clark AD, Diosque M, Vizzotti C. Urueña A, et al. Among authors: giglio n. Vaccine. 2011 Jul 12;29(31):4963-72. doi: 10.1016/j.vaccine.2011.04.111. Epub 2011 May 27. Vaccine. 2011. PMID: 21621575

4

Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.

Giglio N, Gentile A, Lees L, Micone P, Armoni J, Reygrobellet C, Crépey P. Giglio N, et al. Hum Vaccin Immunother. 2012 Mar;8(3):312-22. doi: 10.4161/hv.18569. Epub 2012 Feb 14. Hum Vaccin Immunother. 2012. PMID: 22330959 Free PMC article.

5

Cost-effectiveness analysis of rotavirus vaccination in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C. Urueña A, et al. Among authors: giglio n. Vaccine. 2015 May 7;33 Suppl 1:A126-34. doi: 10.1016/j.vaccine.2014.12.074. Vaccine. 2015. PMID: 25919152

6

Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe.

Wolfson LJ, Castillo ME, Giglio N, Meszner Z, Molnar Z, Vazquez M, Wysocki J, Altland A, Kuter BJ, Rickard J, Rampakakis E. Wolfson LJ, et al. Among authors: giglio n. Hum Vaccin Immunother. 2019;15(4):932-941. doi: 10.1080/21645515.2018.1559687. Epub 2019 Feb 20. Hum Vaccin Immunother. 2019. PMID: 30681397 Free PMC article.

7

Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.

Nguyen VH, Vizzotti C, Uruena A, Giglio N, Magneres C, Richmond H. Nguyen VH, et al. Among authors: giglio n. Vaccine. 2020 Apr 29;38(20):3682-3689. doi: 10.1016/j.vaccine.2020.02.081. Epub 2020 Apr 2. Vaccine. 2020. PMID: 32249017 Free article.

8

Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina.

Urueña A, Micone P, Magneres C, Mould-Quevedo J, Giglio N. Urueña A, et al. Among authors: giglio n. Vaccines (Basel). 2021 Apr 1;9(4):335. doi: 10.3390/vaccines9040335. Vaccines (Basel). 2021. PMID: 33916048 Free PMC article.

9

Cost-Effectiveness of Pneumococcal Vaccines for Adults Aged 65 Years and Older in Argentina.

Giglio ND, Castellano VE, Mizrahi P, Micone PV. Giglio ND, et al. Value Health Reg Issues. 2022 Mar;28:76-81. doi: 10.1016/j.vhri.2021.08.003. Epub 2021 Nov 18. Value Health Reg Issues. 2022. PMID: 34801962 Free article.

10

Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina.

Urueña A, Micone P, Magneres MC, McGovern I, Mould-Quevedo J, Sarmento TTR, Giglio N. Urueña A, et al. Among authors: giglio n. Vaccines (Basel). 2022 Sep 28;10(10):1627. doi: 10.3390/vaccines10101627. Vaccines (Basel). 2022. PMID: 36298493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters